Conventional video-assisted thoracic surgery (VATS) vs. robot-assisted lobectomy: where is the money?
Editorial

Conventional video-assisted thoracic surgery (VATS) vs. robot-assisted lobectomy: where is the money?

Jari Räsänen, Ilkka Ilonen, Jarmo A. Salo

Department of General Thoracic and Esophageal Surgery, HUCH Heart and Lung Center, Helsinki University Hospital, Helsinki University, Haartmaninkatu 4, Helsinki, Finland

Correspondence to: Professor Jarmo A. Salo, MD, Ph.D. Department of General Thoracic and Esophageal Surgery, HUCH Heart and Lung Center, Helsinki University Hospital, Helsinki University, Haartmaninkatu 4, P.O. Box 340, 00029 Helsinki, Finland. Email: jarmo.salo@hus.fi.

Comment on: Louie BE, Wilson JL, Kim S, et al. Comparison of Video-Assisted Thoracoscopic Surgery and Robotic Approaches for Clinical Stage I and Stage II Non-Small Cell Lung Cancer Using The Society of Thoracic Surgeons Database. Ann Thorac Surg 2016. [Epub ahead of print].


Received: 16 August 2016; Accepted: 28 August 2016; Published: 31 August 2016.

doi: 10.21037/vats.2016.08.05


The past 20 years have seen growing evidence for minimally invasive thoracic surgery, namely the widespread adoption of video-assisted thoracic surgery (VATS). The pinnacle of this procedure is the VATS lobectomy, which has thus far spawned multiple adaptations, such as robot-assisted, single-port and subxiphoidal approaches to mention only a few (1-3). Despite much higher adoption rate and more advanced technology, boundaries to conducting safe, efficient, reliably reproducible, minimally invasive surgery persist. Currently, the single-port approach offers no reported benefits over the conventional VATS lobectomy (4,5). Likewise, the robot-assisted VATS approach is reportedly non-inferior to that of conventional VATS (6). Debate about the rationality of the robot-assisted VATS approach is ongoing, as many surgeons feels the costs do not yet offset the benefits of this approach, as direct costs were significantly higher (robot-assisted surgery cost $25,040.70 vs. $20,476.60 for VATS) (7,8). Single-center reports have described higher incidence rates of laryngeal nerve palsy and chylothorax with robot-assisted VATS than with conventional VATS (9). These reports confirm that all of the approaches mentioned here are non-inferior to the conventional multiport VATS approach, and use of these alternative approaches remains the prerogative of the experienced surgeon.

In this study, Dr. Louie and colleagues (10) describe outcomes from the Society of Thoracic Surgeon (STS) database, comparing video-assisted thoracosopic surgery and the robot-assisted approach in stage I and II lobectomies for non-small cell lung cancer (NSCLC). The patients were collected from a 2009 to 2013 timeline. Selected patients underwent minimally invasive procedures. We excluded intended-to-treat (conversions) patients (n=719) as well as low-volume centers (n=1,656) and patients who received preoperative oncologic therapy (n=885). We analyzed the data submitted data from 128 centers, of which 22 used the robot-assisted approach. The study planning initially aimed to conduct propensity-matching analysis, but this was later abandoned due to time constraints. However, these groups shared similar preoperative characteristics, so patient selection should be free of any inherent bias.

As previously published papers show, the study demonstrated that robot-assisted surgery was non-inferior to that of conventional VATS. The results were quite similar to those of a previous report from the STS database (11). In this study, however, the suspected conversion rate for robot-assisted lobectomies was 25.5%, more than 2.4% higher than for conventional VATS. This is understandable, as high conversion rates were associated with the adaptation of the conventional VATS approach also (12). In addition, more robot-assisted surgery patients were preoperatively staged for mediastinal involvement than conventional VATS patients. As this was not the primary outcome for the patient, robot-assisted cases are clearly more likely in tertiary centers of excellence that adopted VATS early, as article discusses. Excluding these centers from the sub analysis could change these results, but the number of patients undergoing the robot-assisted approach would drop precipitously.

On the one hand, one can argue whether robotic lobectomy is indeed a valid option over conventional VATS lobectomy given the higher operative cost and suspected high conversion rate. On the other hand, a similar debate about VATS versus open thoracotomy ensued a decade ago, and the surgical community now considers VATS lobectomy meaningful. As patient outcomes between conventional VATS and robot-assisted lobectomy are currently similar, organizing a prospective randomized study to show any benefit would be an enormous undertaking.

VATS continues to evolve with rapid the development of new technology and acquired experience. Compared to other approaches, robot-assisted surgery holds the greatest potential for the future. Robot-assisted surgery will likely see extraordinary advances over the next decade leading to superior patient outcomes than with conventional approaches. However, the potential of the robot-assisted approach/technique will encounter challenges, as current results for multiport VATS lobectomy are excellent. Time will tell which technique proves to be the most cost effective.


Acknowledgments

The authors thank Ms. Yvonne Sundström for her skillful secretarial assistance.

Funding: None.


Footnote

Provenance and Peer Review: This article was commissioned by the editorial office, Video-Assisted Thoracic Surgery. The article did not undergo external peer review.

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/vats.2016.08.05). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Gharagozloo F, Margolis M, Tempesta B, et al. Robot-assisted lobectomy for early-stage lung cancer: report of 100 consecutive cases. Ann Thorac Surg 2009;88:380-4. [Crossref] [PubMed]
  2. Gonzalez-Rivas D, de la Torre M, Fernandez R, et al. Single-port video-assisted thoracoscopic left upper lobectomy. Interact Cardiovasc Thorac Surg 2011;13:539-41. [Crossref] [PubMed]
  3. Song N, Zhao DP, Jiang L, et al. Subxiphoid uniportal video-assisted thoracoscopic surgery (VATS) for lobectomy: a report of 105 cases. J Thorac Dis 2016;8:S251-7. [PubMed]
  4. Wang BY, Liu CY, Hsu PK, et al. Single-incision versus multiple-incision thoracoscopic lobectomy and segmentectomy: a propensity-matched analysis. Ann Surg 2015;261:793-9. [Crossref] [PubMed]
  5. Shen Y, Wang H, Feng M, et al. Single- versus multiple-port thoracoscopic lobectomy for lung cancer: a propensity-matched study†. Eur J Cardiothorac Surg 2016;49:i48-53. [PubMed]
  6. Kent M, Wang T, Whyte R, et al. Open, video-assisted thoracic surgery, and robotic lobectomy: review of a national database. Ann Thorac Surg 2014;97:236-42; discussion 242-4. [Crossref] [PubMed]
  7. Nasir BS, Bryant AS, Minnich DJ, et al. Performing robotic lobectomy and segmentectomy: cost, profitability, and outcomes. Ann Thorac Surg 2014;98:203-8; discussion 208-9. [Crossref] [PubMed]
  8. Swanson SJ, Miller DL, McKenna RJ Jr, et al. Comparing robot-assisted thoracic surgical lobectomy with conventional video-assisted thoracic surgical lobectomy and wedge resection: results from a multihospital database (Premier). J Thorac Cardiovasc Surg 2014;147:929-37. [Crossref] [PubMed]
  9. Sarkaria IS, Finley DJ, Bains MS, et al. Chylothorax and Recurrent Laryngeal Nerve Injury Associated With Robotic Video-Assisted Mediastinal Lymph Node Dissection. Innovations (Phila) 2015;10:170-3. [Crossref] [PubMed]
  10. Louie BE, Wilson JL, Kim S, et al. Comparison of Video-Assisted Thoracoscopic Surgery and Robotic Approaches for Clinical Stage I and Stage II Non-Small Cell Lung Cancer Using The Society of Thoracic Surgeons Database. Ann Thorac Surg 2016; [Epub ahead of print]. [PubMed]
  11. Farivar AS, Cerfolio RJ, Vallières E, et al. Comparing robotic lung resection with thoracotomy and video-assisted thoracoscopic surgery cases entered into the Society of Thoracic Surgeons database. Innovations (Phila) 2014;9:10-5. [Crossref] [PubMed]
  12. Hansen HJ, Petersen RH, Christensen M. Video-assisted thoracoscopic surgery (VATS) lobectomy using a standardized anterior approach. Surg Endosc 2011;25:1263-9. [Crossref] [PubMed]
doi: 10.21037/vats.2016.08.05
Cite this article as: Räsänen J, Ilonen I, Salo JA. Conventional video-assisted thoracic surgery (VATS) vs. robot-assisted lobectomy: where is the money? Video-assist Thorac Surg 2016;1:8.

Download Citation